cannabis indica

Índice completo — página 62 de 77

Estudos 6.101 a 6.200 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2012. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 6.101 a 6.200

  1. 2012

    AM-251 and Rimonabant Act as Direct Antagonists at Mu-Opioid Receptors: Implications for Opioid/Cannabinoid Interaction Studies

  2. 2012

    An accidental fatal intoxication with methoxetamine

  3. 2012

    An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — CrônicaArtriteProteína Ligadora de Ácidos Graxos (FABP)+1
  4. 2012

    An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain

    FavorávelEnsaio Clínico Duplo-CegoDorAnsiedadeDor — CrônicaTHC Farmacêutico+4
  5. 2012

    An open-label extension study to investigate the long-term safety and tolerability of THC/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics

  6. 2012

    Anti-proliferative and anti-angiogenic effects of CB2R agonist (JWH-133) in non-small lung cancer cells (A549) and human umbilical vein endothelial cells: an in vitro investigation

    FavorávelEstudo LaboratorialCâncerCâncer — PulmãoCanabinoides Sintéticos JWH-x
  7. 2012

    Anti-tumor activity of the novel hexahydrocannabinol analog LYR-8 in Human colorectal tumor xenograft is mediated through the inhibition of Akt and hypoxia-inducible factor-1α activation.

    FavorávelEstudo LaboratorialCâncerCâncer — Cólon
  8. 2012

    Anticonvulsant effect of phytol in a pilocarpine model in mice

    FavorávelEstudo em AnimaisEpilepsiaEpilepsia — Lennox-Gastaut
  9. 2012

    Antidepressant activity of Litsea glaucescens essential oil: Identification of β-pinene and linalool as active principles

    FavorávelEstudo LaboratorialDorAnsiedadeDepressãoMedicina Mente-Corpo+7
  10. 2012

    Antimicrobial effect of linalool and α-terpineol against periodontopathic and cariogenic bacteria

    FavorávelEstudo LaboratorialInfecções BacterianasDoença PeriodontalDor — Dentária Aguda
  11. 2012

    Association of Herbal Cannabis Use With Negative Psychosocial Parameters in Patients With Fibromyalgia

    InconclusivoMetanáliseEfeitos Adversos da CannabisFibromialgia
  12. 2012

    Association of Marijuana Use and Cyclic Vomiting Syndrome

    DesfavorávelMetanáliseNáusea e VômitoSíndrome da Hiperêmese Canabinoide
  13. 2012

    Attitudes and perceptions towards substances among people with mental disorders: a systematic review

    DesfavorávelMetanálise ClínicaDependência QuímicaTetraidrocanabinol (THC)
  14. 2012

    Biological activities of α-pinene and β-pinene enantiomers.

    FavorávelEstudo LaboratorialInfecções FúngicasInfecção por Estafilococos
  15. 2012

    Borneol administration protects primary rat hepatocytes against exogenous oxidative DNA damage

    FavorávelEstudo em AnimaisDoença Hepática Alcoólica
  16. 2012

    Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?

  17. 2012

    Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy

    DesfavorávelMetanálise ClínicaTiques e Síndrome de Tourette
  18. 2012

    Cannabidiol And Clozapine Reverse MK-801-induced Deficits In Social Interaction And Hyperactivity In Sprague-Dawley Rats

    FavorávelEstudo em AnimaisTDA e TDAH
  19. 2012

    Cannabidiol As Potential Anticancer Drug

  20. 2012

    Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.

    FavorávelEnsaio Clínico Duplo-CegoPsicoseEsquizofreniaAnandamida (AEA)Hidrolase de Amidas de Ácidos Graxos (FAAH)+1
  21. 2012

    Cannabidiol Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma–Associated Herpesvirus-Infected Endothelium

    FavorávelEstudo LaboratorialSarcoma de Kaposi
  22. 2012

    Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1

    FavorávelEstudo em AnimaisCâncerCâncer — PulmãoTetraidrocanabinol (THC)
  23. 2012

    Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

    DesfavorávelEnsaio ClínicoDisfunção CognitivaPsicose
  24. 2012

    Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Lesão de Reperfusão
  25. 2012

    Cannabidiol-treated rats exhibited higher motor score after cryogenic spinal cord injury.

    FavorávelEstudo em AnimaisDoenças NeurodegenerativasLesões da Medula Espinhal
  26. 2012

    Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug

    FavorávelMetanáliseAnsiedadeTEPTTOC
  27. 2012

    Cannabidiolic acid, a major cannabinoid in fiber-type cannabis, is an inhibitor of MDA-MB-231 breast cancer cell migration.

    FavorávelEstudo LaboratorialCâncerCâncer — MamaÁcido Canabidiólico (CBD-a)
  28. 2012

    Cannabidivarin is anticonvulsant in mouse and rat

    FavorávelEstudo em AnimaisEpilepsiaCanabidivarina (CBDV)
  29. 2012

    Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation

  30. 2012

    Cannabinoid CB1 Receptors Mediate the Gastroprotective Effect of Neurotensin

    FavorávelEstudo em AnimaisÚlcera GástricaCanabinoides Sintéticos AM-x
  31. 2012

    Cannabinoid Hyperemesis

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  32. 2012

    Cannabinoid hyperemesis syndrome: a case series and review of previous reports

    DesfavorávelMetanáliseNáusea e VômitoSíndrome da Hiperêmese Canabinoide
  33. 2012

    Cannabinoid Hyperemesis: A Case Series of 98 Patients

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  34. 2012

    Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy.

    FavorávelEstudo em AnimaisNefropatia DiabéticaCanabinoides Sintéticos AM-x
  35. 2012

    Cannabinoid receptor 2 is upregulated in melanoma

    InconclusivoEstudo LaboratorialCâncerCâncer — Melanoma
  36. 2012

    Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis

  37. 2012

    Cannabinoid signalling regulates inflammation and energy balance: the importance of the brain-gut axis

  38. 2012

    Cannabinoids for epilepsy

    InconclusivoMetanálise ClínicaEpilepsia
  39. 2012

    Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting.

    FavorávelMetanáliseNáusea e VômitoTHC Farmacêutico
  40. 2012

    Cannabinoids: novel medicines for the treatment of Huntington's disease

    FavorávelMetanáliseDoença de HuntingtonDistoniaCoreiaTHC:CBD Farmacêutico
  41. 2012

    Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers

    InconclusivoEnsaio Clínico Duplo-CegoPsicose
  42. 2012

    Cannabis hyperemesis syndrome

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  43. 2012

    Cannabis—A Valuable Drug That Deserves Better Treatment

  44. 2012

    CB(1) blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans

  45. 2012

    CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint

    FavorávelEstudo em AnimaisInflamaçãoArtriteArtrite — OsteoartriteAcupuntura (MTC)
  46. 2012

    Chemical and biological analyses of the essential oils and main constituents of Piper species.

    FavorávelEstudo LaboratorialLeishmaniose
  47. 2012

    Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer.

    FavorávelEstudo em AnimaisCâncerCâncer — Cólon
  48. 2012

    Clinical correlates of co-occurring cannabis and tobacco use: a systematic review

  49. 2012

    Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery

  50. 2012

    Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: recent advances and challenges

    InconclusivoMetanáliseCâncerCâncer — Boca
  51. 2012

    Correlations and agreement between delta-9-tetrahydrocannabinol (THC) in blood plasma and timeline follow-back (TLFB)-assisted self-reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial

  52. 2012

    Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue

  53. 2012

    D-Limonene modulates inflammation, oxidative stress and Ras-ERK pathway to inhibit murine skin tumorigenesis.

    FavorávelEstudo em AnimaisCâncerInflamaçãoEstresse Oxidativo+2
  54. 2012

    Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III.

    FavorávelMetanáliseDiabetes
  55. 2012

    Detecting impairment associated with cannabis with and without alcohol on the Standardized Field Sobriety Tests.

  56. 2012

    Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex

    FavorávelEstudo LaboratorialCondições GeriátricasLongevidade
  57. 2012

    Does olanzapine inhibit the psychomimetic effects of Δ⁹-tetrahydrocannabinol?

    FavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisPsicose
  58. 2012

    Does rimonabant independently affect free fatty acid and glucose metabolism?

  59. 2012

    Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1⁻/⁻ mice

    FavorávelEstudo em AnimaisDisfunção CognitivaCondições GeriátricasLongevidade
  60. 2012

    Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial

    FavorávelEnsaio Clínico Duplo-CegoTraumatismo CranioencefálicoCanabinoide Sintético (não especificado)
  61. 2012

    Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission.

    FavorávelEstudo em AnimaisDepressãoTetraidrocanabinol (THC)Canabinoides Sintéticos SR-x
  62. 2012

    Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.

  63. 2012

    Effects of δ9-tetrahydrocannabinol on human working memory function

  64. 2012

    Efficacy of rimonabant in obese patients with binge eating disorder

  65. 2012

    Electroacupuncture inhibits CB1 upregulation induced by ethanol withdrawal in mice

    FavorávelEstudo em AnimaisDependência QuímicaDependência — ÁlcoolAcupuntura (MTC)
  66. 2012

    Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor

    InconclusivoEstudo em AnimaisTOCAnandamida (AEA)Canabinoide Sintético (não especificado)+1
  67. 2012

    Endocannabinoid Signaling, Glucocorticoid-Mediated Negative Feedback and Regulation of the HPA Axis.

    FavorávelMetanáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  68. 2012

    Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension.

  69. 2012

    Evaluation of acute toxicity of a natural compound (+)-limonene epoxide and its anxiolytic-like action

    FavorávelEstudo em AnimaisAnsiedadeDependência — Benzodiazepínicos
  70. 2012

    Fatty acid flux and oxidation are increased by rimonabant in obese women

  71. 2012

    Fear-induced suppression of nociceptive behaviour and activation of Akt signalling in the rat periaqueductal grey: role of fatty acid amide hydrolase

    InconclusivoEstudo em AnimaisDorDor — AgudaHidrolase de Amidas de Ácidos Graxos (FAAH)
  72. 2012

    Glucocorticoid-endocannabinoid interaction in cardiac surgical patients: relationship to early cognitive dysfunction and late depression

  73. 2012

    Human abuse potential and cognitive effects of taranabant, a cannabinoid 1 receptor inverse agonist: a randomized, double-blind, placebo- and active-controlled, crossover study in recreational polydrug users

  74. 2012

    Identification of receptors and enzymes for endocannabinoids in NSC-34 cells: relevance for in vitro studies with cannabinoids in motor neuron diseases

  75. 2012

    Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study

  76. 2012

    Inactivation of fatty acid amide hydrolase exacerbates experimental fibrosis by enhanced endocannabinoid-mediated activation of CB1

  77. 2012

    Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis

    DesfavorávelMetanálise ClínicaTetraidrocanabinol (THC)
  78. 2012

    Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing

    InconclusivoEnsaio Clínico Duplo-CegoPsicose
  79. 2012

    Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice

  80. 2012

    Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression

    FavorávelEnsaio ClínicoDepressãoAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  81. 2012

    Interictal type 1 cannabinoid receptor binding is increased in female migraine patients

    FavorávelMetanáliseEnxaqueca
  82. 2012

    Investigation of mechanisms involved in (-)-borneol-induced vasorelaxant response on rat thoracic aorta

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)
  83. 2012

    Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation

    InconclusivoEstudo em AnimaisDermatite de Contato AlérgicaBronquite2-Araquidonoilglicerol (2-AG)
  84. 2012

    L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease

  85. 2012

    Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes

  86. 2012

    Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: association with wrist cutting as impulsive self-injurious behavior

    InconclusivoMetanáliseAnorexia (perda de apetite)Anorexia Nervosa
  87. 2012

    Lysophosphatidylinositol signalling: new wine from an old bottle

    DesfavorávelMetanáliseCâncerLisofosfatidilinositol (LPI)
  88. 2012

    Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide

  89. 2012

    Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders.

    FavorávelEstudo em AnimaisDisfunção CognitivaDoenças Neurodegenerativas
  90. 2012

    Minireview: Endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior.

  91. 2012

    Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence.

    FavorávelMetanáliseTEPT
  92. 2012

    Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids

    InconclusivoEstudo LaboratorialDorCâncerCanabinoides Sintéticos AM-xCanabinoides Sintéticos WIN-x+11
  93. 2012

    Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system

  94. 2012

    Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders

    FavorávelMetanáliseAnsiedadeDepressãoPsicose
  95. 2012

    Multiple sclerosis and extract of cannabis: results of the MUSEC trial

    FavorávelEnsaio Clínico Duplo-CegoDorInsônia e Distúrbios do SonoEsclerose Múltipla
  96. 2012

    Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerDor — CrônicaTHC:CBD Farmacêutico+3
  97. 2012

    Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans

    InconclusivoEnsaio Clínico Duplo-CegoDorEfeitos Adversos da CannabisDependência — CannabisAnandamida (AEA)+5
  98. 2012

    Neuromodulators for pain management in rheumatoid arthritis

    FavorávelMetanáliseArtriteArtrite — Reumatoide
  99. 2012

    Neuronal populations mediating the effects of endocannabinoids on stress and emotionality.

    FavorávelMetanáliseEndocanabinoide (não especificado)
  100. 2012

    Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects

    FavorávelEnsaio Clínico Duplo-CegoDorCâncerEsclerose MúltiplaTHC Farmacêutico+4